Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 133 blog entries.

MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd)

Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) Drug alert number: EL (24)A/07 Date issued: 26 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm [...]

The post MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) appeared first on Community Pharmacy England.

By |February 26th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd)

National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

National Patient Safety Alert: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials National Patient Safety Alert Reference Number: NatPSA/2024/003/DHSC_MVA Date issued: 26 February 2024 Explanation of identified safety issue A Medicines Supply Notification (MSN) issued on 14 February 2024, detailed a shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid. The resolution date [...]

The post National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials appeared first on Community Pharmacy England.

By |February 26th, 2024|Lexpos News|Comments Off on National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

February 2024 Price Concessions 3rd Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (23/02/2024) announced the following list of price concessions for February 2024. Please note: We are still in discussion with DHSC on a number other medicines affected by pricing [...]

The post February 2024 Price Concessions 3rd Update appeared first on Community Pharmacy England.

By |February 23rd, 2024|Lexpos News|Comments Off on February 2024 Price Concessions 3rd Update

MHRA Drug Safety Update: February 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 7 February 2024) has been published and includes articles on: Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) Letters and medicine recalls sent [...]

The post MHRA Drug Safety Update: February 2024 appeared first on Community Pharmacy England.

By |February 20th, 2024|drug safety, Lexpos News, mhra, safety|Comments Off on MHRA Drug Safety Update: February 2024

MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited)

Drug alert number: EL (24)A/05 Date issued: 12 February 2024 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited) PL 36687/0222 SNOMED Code: 36834211000001109 Batch Number Expiry Date Pack Size First Distributed MG21264 29/02/2024 28 tablets 13/12/2021 MG21334 31/03/2024 28 tablets [...]

The post MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited) appeared first on Community Pharmacy England.

By |February 13th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited)